$73M Mesh Verdict Shows Email Evidence's Sway Over Jurors

The pelvic mesh trial that unleashed a $73 million verdict against Boston Scientific Corp. stood out in one crucial way from two similar bellwethers won by the device maker: It dredged...

Already a subscriber? Click here to view full article